“Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models”. Journal of Kidney Cancer 12, no. 3 (September 26, 2025): 58–65. Accessed November 12, 2025. https://jkcvhl.com/index.php/jkcvhl/article/view/427.